TechNavio today launched its report, Impact of Patent Expirations on Key Drugs Categories 2012-2016 – A Survey Report, based on an in-depth analysis covering the Americas, and the EMEA and APAC regions. The report aims to aid decision makers’ understanding of the present and future landscape of the market.
Commenting on the report, an analyst from TechNavio’s Healthcare team said: ”The Asia Pacific (APAC) region is expected to post the highest growth rate in the Global Pharmaceuticals market during the forecast period. Currently, the Americas dominates both the Branded Pharmaceuticals market and the Generic Pharmaceuticals market. The leading countries that contribute to the Global Pharmaceuticals market are the US, Japan, Germany, China, and India.”
According to the report, the Global Generic Drugs market is expected to grow at a rapid pace during the period 2011-2015. Generic drugs are replicas of branded drugs; they have the same strength, quality, dosage specifications, method of administration, performance characteristics, risks, and safety as their branded counterparts. Overall, the demand for patented drugs is expected to remain positive with the increasing demand for new drugs.
Further, the report reveals that the patent expiry of a product affects not only the sales of this drug, but also the sales of other drugs in the same drug category.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors. For further information on this report, please visit https://www.technavio.com/content/impact-patent-expiration-key-drugs-cate…
TechNavio, the market research platform of Infiniti Research Ltd, publishes periodic market research reports on niche and emerging technologies. For more information on our Healthcare market research, please visit https://www.technavio.com/healthcare
Follow us on Twitter @ Technavio
TechNavio Announces the Publication of its Research Report – Impact of Patent Expirations on Key Drugs Categories 2012-2016 – A Survey Report
